LV-TRE-VP64 mouse MyoD-T2A-dsRedExpress2 Citations (3)

Originally described in: Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain.
Kabadi AM, Thakore PI, Vockely CM, Ousterout DG, Gibson TM, Guilak F, Reddy TE, Gersbach CA ACS Synth Biol. 2014 Dec 10. PubMed Journal

---

Articles Citing LV-TRE-VP64 mouse MyoD-T2A-dsRedExpress2

Articles
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors. Jin Y, Shen Y, Su X, Weintraub N, Tang Y. J Vis Exp. 2019 Sep 14;(151). doi: 10.3791/59432. PubMed
Effective restoration of dystrophin expression in iPSC (Mdx)-derived muscle progenitor cells using the CRISPR/Cas9 system and homology-directed repair technology. Jin Y, Shen Y, Su X, Weintraub NL, Tang Y. Comput Struct Biotechnol J. 2020 Mar 25;18:765-773. doi: 10.1016/j.csbj.2020.03.012. eCollection 2020. PubMed
MyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro: protocols and their applications. Rossi R, Torelli S, Ala P, Weston W, Morgan J, Malhotra J, Muntoni F. Front Physiol. 2023 May 17;14:1145047. doi: 10.3389/fphys.2023.1145047. eCollection 2023. PubMed

If you have published an article using this material, please email us at to have your article added to this page.